EUVIMEDEUVIMED entdecken
Crossref

Innate Immunity‐Guided Macrophage‐Homing Nanoplatform for Oral Tumor Immunotherapy and Real‐Time Deep‐Tissue Imaging in Pre‐Clinical Models

Putry Yosefa Siboro, Nhien Nguyen, Shih-Kai Lo, Fwu-Long Mi, Wen-Wei Wu, Che-Hung Wang, Yun-Ching Chen, Wei-Lun Pan, Sheng-Yao Peng, Lam-Duc-Huy Nguyen, Kun-Ju Lin, Hsing-Wen Sung iD

Advanced Materials · 2025

DOI: 10.1002/adma.202507607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Putry Yosefa Siboro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan (ROC). Hauptthemen laut MEDLINE: Macrophages, Immunotherapy, Immunity, Innate, Nanoparticles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan, Chang Gung Memorial Hospital and National Tsing Hua University Joint Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with poor prognosis and a high propensity for liver metastasis. This study presents an innate immunity‐guided, macrophage (MΦ)‐homing nanoplatform that enables oral delivery of theranostic agents to PDAC lesions by harnessing the migratory behavior of endogenous MΦ toward tumor‐derived immune cues. The nanoplatform integrates a βGlus‐R848 prodrug—constructed by conjugating β‐glucans (βGlus) with the immunomodulator resiquimod (R848) via a reactive oxygen species (ROS)‐responsive thioketal linker—and Ag 2 Te quantum dots (QDs) for near‐infrared II (NIR‐II) imaging, forming βGlus‐R848/Ag 2 Te nanoparticles (NPs). Upon oral administration, βGlus facilitates the selective uptake of NPs by intestinal MΦ (βGlus‐R848/Ag 2 Te NPs@MΦ), which subsequently migrate to the tumor microenvironment (TME). There, elevated ROS levels trigger the release of R848, reprogramming tumor‐associated MΦ from an immunosuppressive M2 to an immunoactive M1 phenotype. This immune activation remodels the stroma, enhances T cell infiltration, and transforms the TME into an immunoactive state, thereby improving therapeutic outcomes. Concurrently, Ag 2 Te QDs enable deep‐tissue NIR‐II imaging for real‐time visualization of PDAC progression, liver metastasis, and treatment response. Guided by innate immune signals, this MΦ‐homing theranostic platform offers a promising strategy to overcome current challenges in PDAC treatment by integrating targeted immunotherapy with noninvasive, real‐time disease monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesImmunotherapyImmunity, InnateNanoparticlesPancreatic NeoplasmsCarcinoma, Pancreatic DuctalAnimalsMiceTumor MicroenvironmentHumansQuantum DotsCell Line, TumorReactive Oxygen SpeciesImidazolesAdministration, OralProdrugsbeta-Glucans

Stichwörter der Autor:innen

NIR‐II imagingcellular carriermacrophage polarizationoral drug deliverytargeted immunotherapy

Substanzen

resiquimodReactive Oxygen SpeciesImidazolesProdrugsbeta-Glucans

Autor:innen und Institutionen

  • Department of Chemical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan (ROC).
  • Department of Biochemistry and Molecular Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 23142, Taiwan (ROC).
  • Department of Materials Science and Engineering, National Yang Ming Chiao Tung University, Hsinchu, 30010, Taiwan (ROC).
  • Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, 30013, Taiwan (ROC).
  • Department of Nuclear Medicine and Center for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan (ROC).

ORCID-Profile: Hsing-Wen Sung

Förderung

  • Ministry of Science and Technology, Taiwan
  • Chang Gung Memorial Hospital and National Tsing Hua University Joint Research Program

Zitieren

APA

Siboro, P. Y., Nguyen, N., Lo, S. K., Mi, F. L., Wu, W. W., Wang, C. H., Chen, Y. C., Pan, W. L., Peng, S. Y., Nguyen, L. D., Lin, K. J., & Sung, H. W. (2025). Innate Immunity‐Guided Macrophage‐Homing Nanoplatform for Oral Tumor Immunotherapy and Real‐Time Deep‐Tissue Imaging in Pre‐Clinical Models. Advanced Materials. https://doi.org/10.1002/adma.202507607

Vancouver

Siboro PY, Nguyen N, Lo SK, Mi FL, Wu WW, Wang CH, et al. Innate Immunity‐Guided Macrophage‐Homing Nanoplatform for Oral Tumor Immunotherapy and Real‐Time Deep‐Tissue Imaging in Pre‐Clinical Models. Advanced Materials. 2025. doi:10.1002/adma.202507607

BibTeX
@article{Siboro2025,
  author = {Siboro, Putry Yosefa and Nguyen, Nhien and Lo, Shih-Kai and Mi, Fwu-Long and Wu, Wen-Wei and Wang, Che-Hung and Chen, Yun-Ching and Pan, Wei-Lun and Peng, Sheng-Yao and Nguyen, Lam-Duc-Huy and Lin, Kun-Ju and Sung, Hsing-Wen},
  title = {Innate Immunity‐Guided Macrophage‐Homing Nanoplatform for Oral Tumor Immunotherapy and Real‐Time Deep‐Tissue Imaging in Pre‐Clinical Models},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202507607}
}
Kostenlos starten →